ZL-2306 (Nirapairb) + Placebo Comparator
Phase 3UNKNOWN 0 watching 0 views this week๐ Rising
72
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 24
Phase 35
ApprovedIndication / Disease
Ovarian Cancer
Conditions
Ovarian Cancer
Trial Timeline
Jun 30, 2018 โ Dec 30, 2023
NCT ID
NCT03709316About ZL-2306 (Nirapairb) + Placebo Comparator
ZL-2306 (Nirapairb) + Placebo Comparator is a phase 3 stage product being developed by Zai Lab for Ovarian Cancer. The current trial status is unknown. This product is registered under clinical trial identifier NCT03709316. Target conditions include Ovarian Cancer.
Hype Score Breakdown
Clinical
27
Activity
18
Company
5
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03709316 | Phase 3 | UNKNOWN |
Competing Products
20 competing products in Ovarian Cancer